Buy Rating for Arcellx Inc. Based on Promising Efficacy and Safety of BCMA CAR-T Therapy in IMMagine-1 Study

TipRanksDec 12 02:06 ET · Ratings

Morgan Stanley Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $111

Moomoo NewsDec 11 08:33 ET · Ratings

Truist Financial Initiates Arcellx(ACLX.US) With Buy Rating

Moomoo NewsDec 11 08:33 ET · Ratings

A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $111 to $122

Moomoo NewsDec 11 08:00 ET · Ratings

Promising Outlook for Arcellx Inc: Anito-cel Therapy Positioned as a Safer Alternative With Strong Market Potential

TipRanksDec 11 05:45 ET

Arcellx Is Maintained at Buy by UBS

Dow JonesDec 10 13:09 ET · Ratings